<SEC-DOCUMENT>0001601830-21-000016.txt : 20210813
<SEC-HEADER>0001601830-21-000016.hdr.sgml : 20210813
<ACCEPTANCE-DATETIME>20210813075549
ACCESSION NUMBER:		0001601830-21-000016
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210813
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210813
DATE AS OF CHANGE:		20210813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RECURSION PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001601830
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				464099738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40323
		FILM NUMBER:		211169769

	BUSINESS ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101
		BUSINESS PHONE:		(385) 269-0203

	MAIL ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Recursion Pharmaceuticals, LLC
		DATE OF NAME CHANGE:	20140305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rxrx-20210813.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:9d5aea7c-67e3-4454-a7c1-467c78f28566,g:86614da4-bb51-4082-99bb-fc6637ee7a56,d:626e47bc033d4513b86b0c0d1c49f8e5--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rxrx-20210813</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV8xLTEtMS0xLTA_cc6bcb34-3ea7-4d46-9e60-85c9db333e21">0001601830</ix:nonNumeric><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV8yLTEtMS0xLTA_2536a590-b32c-471f-9d16-020c9cf21eae">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV8zLTEtMS0xLTA_43245ed0-c211-4427-9bd6-8ec2b2ecc206">2021</ix:nonNumeric><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV80LTEtMS0xLTA_4045bef3-6c5a-46d2-a8f8-602ce3ec1a43">Q2</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rxrx-20210813.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-13</xbrli:startDate><xbrli:endDate>2021-08-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i626e47bc033d4513b86b0c0d1c49f8e5_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjU0_1fb77831-100f-4a57-9991-337477cb7231">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of The Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xMDk5NTExNjI5NDQ3_713c4f8e-6e00-4da2-a6c4-84a432a1a86d">August&#160;13, 2021</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8yMzE_cff701ca-4d43-4637-b552-d26d3fbfac33">Recursion Pharmaceuticals, Inc.</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6ZDMwYTZiNDRhOGY4NGFiMTgyN2M2MjE0MGUzNzQ4MDcvdGFibGVyYW5nZTpkMzBhNmI0NGE4Zjg0YWIxODI3YzYyMTQwZTM3NDgwN18wLTAtMS0xLTA_5444bcb0-7d7a-4559-a798-35a80816cf89">Delaware</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6ZDMwYTZiNDRhOGY4NGFiMTgyN2M2MjE0MGUzNzQ4MDcvdGFibGVyYW5nZTpkMzBhNmI0NGE4Zjg0YWIxODI3YzYyMTQwZTM3NDgwN18wLTItMS0xLTAvdGV4dHJlZ2lvbjpjMDNmYjhmZjU1YWE0NTEwODYxNTE5OTA2ZWI2NjllYV81_6b6a52a0-31db-4505-a554-654cca95ca16">001-40323</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#160;<ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6ZDMwYTZiNDRhOGY4NGFiMTgyN2M2MjE0MGUzNzQ4MDcvdGFibGVyYW5nZTpkMzBhNmI0NGE4Zjg0YWIxODI3YzYyMTQwZTM3NDgwN18wLTQtMS0xLTA_9ee11584-04ca-469d-8f00-2b30df1274bb">46-4099738</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8yOTQ_eea946b3-082f-4b91-80f1-ca41ac1e829c">41 S Rio Grande Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8yOTc_c78df273-6bf4-4b28-b75c-4c3bcdeb99a9">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zMDE_aff885b5-2f09-42a2-b1c0-054f853c94ce">UT</ix:nonNumeric> <ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zMDQ_544cc06b-3c90-412f-a2ba-81bb93b5c1bf">84101</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zNjE_b138e4ee-6a10-46e7-8311-a16598aab626">385</ix:nonNumeric>) <ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zNjU_9ff983dc-df54-4dca-9f96-562b21c34279">269 - 0203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjYw_1678b313-c6ce-4967-81f2-b94e959b62ae">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjYy_6af9d919-2a95-4ac2-8665-016db185944a">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjU3_bb208de3-88c2-40c5-aa26-c4112b3549f9">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjU5_01523f30-3e95-4a00-a6fb-04b3322055ef">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">240.13e-4(c))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6NjE3NGIzNTIyNDUxNDYwYjg2OTgyM2JiZTJlODFjYWUvdGFibGVyYW5nZTo2MTc0YjM1MjI0NTE0NjBiODY5ODIzYmJlMmU4MWNhZV8xLTAtMS0xLTA_bc153ec4-7730-416e-9303-c67127f9e616">Class A Common Stock, par value $0.00001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6NjE3NGIzNTIyNDUxNDYwYjg2OTgyM2JiZTJlODFjYWUvdGFibGVyYW5nZTo2MTc0YjM1MjI0NTE0NjBiODY5ODIzYmJlMmU4MWNhZV8xLTEtMS0xLTA_959758e0-b5e7-45b0-a85b-c7d674447f90">RXRX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6NjE3NGIzNTIyNDUxNDYwYjg2OTgyM2JiZTJlODFjYWUvdGFibGVyYW5nZTo2MTc0YjM1MjI0NTE0NjBiODY5ODIzYmJlMmU4MWNhZV8xLTItMS0xLTA_d4c4ba5f-5657-42ba-a340-cad10d748cdd">Nasdaq Global Select Market</ix:nonNumeric> </span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjYz_354e5965-de31-4ac0-ae48-a9abb30d0b81">x</ix:nonNumeric></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  <ix:nonNumeric contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjY0_f5b768dd-a73b-4608-a317-0ab6294d25f8">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div id="i626e47bc033d4513b86b0c0d1c49f8e5_7"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;13, 2021, Recursion Pharmaceuticals, Inc. issued a press release announcing its results of operations and financial condition for the second quarter ended June&#160;30, 2021. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information pursuant to Item 2.02 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div id="i626e47bc033d4513b86b0c0d1c49f8e5_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-q0221.htm">Press release issued by Recursion Pharmaceuticals, Inc. dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-q0221.htm">A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-q0221.htm">ugust</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-q0221.htm"> 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-q0221.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-q0221.htm">, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div id="i626e47bc033d4513b86b0c0d1c49f8e5_13"></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August&#160;13, 2021.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RECURSION PHARMACEUTICALS, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Secora</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael Secora</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-q0221.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i50db24f375cc46d9869b5850c1549370_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Exhibit 99.1</font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Recursion Reports Second Quarter 2021 Financials and Provides Business Updates</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">Expanded the total number of research and development programs from 37 to 48</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">Announced first internally-developed NCE is advancing to IND-enabling studies</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">Planning to expand operations to Canada, with Toronto serving as a multidisciplinary hub</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">Formed Therapeutics Advisory Board chaired by Joseph Miletich, MD, PhD</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SALT LAKE CITY, August&#160;13, 2021</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8212; Recursion (Nasdaq &#58; RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, today reported financial results and business updates for its second quarter ending June&#160;30, 2021. </font></div><div><font><br></font></div><div><img alt="rxrx-20210630_g2a.jpg" src="rxrx-20210630_g2a.jpg" style="height:351px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#34;We are excited with how Recursion is expanding across many fronts in order to deliver on our mission to decode biology to radically improve lives,&#34; said Recursion Co-Founder &#38; CEO Chris Gibson, PhD. &#34;Not only is the company continuing to advance and expand the total number of its research and development programs, but we are expanding our operations to Canada to grow our capabilities and workforce and we are enhancing our expertise in research and development by forming a Therapeutics Advisory Board. Moreover, the company continues to build on its medicinal chemistry expertise, resulting in our first internally-developed new chemical entity being advanced to IND-enabling studies for potential treatment of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">C. difficile </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">colitis.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Recursion finished the second quarter of 2021 with a portfolio of 4 clinical stage programs, 4 preclinical programs, 7 late discovery programs, and 33 early discovery programs, for a total of 48 research and development programs. Additionally, Recursion continued scaling the total number of executed phenomic experiments to over 82 million, the size of its proprietary data universe to approximately 9 petabytes, and the number of biological inferences to over 179 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">billion. Data have been generated across 37 human cell types, an in-house chemical library of over 706 thousand compounds, an </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">in silico</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> library of over 12 billion small molecules, and a growing team of more than 270 Recursionauts that is balanced between life scientists and computational and technical experts. The power of the Recursion OS is exemplified by the breadth of active research and development programs.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Summary of Business Highlights</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Clinical Programs</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Familial adenomatous polyposis (FAP) (REC-4881)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We plan to initiate a Phase 2, randomized, double-blind, placebo-controlled study to evaluate safety, pharmacokinetics, and efficacy of REC-4881 in classical FAP patients within the next 3 to 4 quarters.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Cerebral cavernous malformation (REC-994)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We plan to initiate a Phase 2, double-blind, placebo-controlled safety, tolerability and exploratory efficacy study of REC-994 in the next 3 to 4 quarters.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Neurofibromatosis type 2 (REC-2282)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We plan to initiate a parallel group, two stage, Phase 2&#47;3, randomized, multicenter study within the next 3 to 4 quarters.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">GM2 gangliosidosis (REC-3599)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We plan to initiate a Phase 2 trial in the next 3 to 4 quarters.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Notable Preclinical Programs</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Clostridium difficile colitis (REC-3964)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">REC-3964 is an orally active, gut biased, small molecule </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">C. difficile</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> toxin B inhibitor, selected as Recursion&#8217;s first internally-developed new chemical entity (NCE) to advance to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">investigational new drug</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> (IND)-enabling studies.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Immune checkpoint resistance in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">STK11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">-mutant non-small cell lung cancer (NSCLC)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The lead molecule has completed dose optimization studies and has advanced into pharmacodynamic studies in rodent NSCLC models of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">STK11-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">mediated checkpoint resistance.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Notable Late Discovery Programs</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Cancer immunotherapy, target &#8216;alpha&#8217;&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> Undisclosed target &#8216;alpha&#8217; was selected based on an inferential assessment of the strength of its relationship to known genes impacting immunotherapy response. A small molecule inhibitor of target alpha demonstrated robust single agent and combination activity with anti-PD1 in a CT26 model of immune checkpoint resistance, achieving 40% complete response in the combination arm.  </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Neuroinflammation&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Multiple molecules from the lead chemical series demonstrated attenuated anti-inflammatory cytokine responses in a mouse pharmacodynamic model of neuroinflammation. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Oncology - small molecule MYC Inhibitors&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Digital chemistry tools expanded multiple hit series with evidence of structure activity relationship. Multiple series are prioritized and undergoing optimization.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Batten disease&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Multiple small molecule candidates are being evaluated in rodent pharmacodynamic models of Batten disease. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Charcot-Marie-Tooth type 2A (CMT2A)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Multiple small molecule mechanistic classes will be assessed in a rodent model of CMT2A. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Bayer AG Partnership&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We continue to make progress in our collaboration with Bayer to discover small molecule drug candidates with the potential to treat fibrotic diseases. In the collaboration&#8217;s first year we have developed novel disease models and successfully </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">leveraged the Recursion Operating System, or Recursion OS, to identify numerous active molecules and promising chemical families.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Platform</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">PhenoMap Extensions&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We began generating arrayed whole genome knockout and compound library PhenoMaps in two additional cell types. Additionally, we have made substantial progress in onboarding astrocytes as our first neuronal cell type.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Chemical Technology&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Over the past quarter, we have incorporated additional virtual chemical library search methods into our digital chemistry tools and have begun reading out positive results from our first large-scale expansion searches for our NCE programs.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.11pt">Orthogonomics&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We have more than doubled the total number of genes and proteins measured in transcriptomic and proteomic experiments during the past quarter, leveraging these studies across multiple programs to discover new in vitro disease biomarkers that we may use to assess the efficacy of compounds.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Facilities and Manufacturing&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> We have two construction projects in progress to expand our current headquarters and create a chemistry, manufacturing and controls (CMC) site in Salt Lake City. The expansion will allow us to improve our current platform by increasing capacity and automation, growing our compound and biobank libraries, further scaling proteomics and transcriptomics capabilities, and beginning the buildout of automated chemical compound microsynthesis. The CMC site will bolster our capabilities in analytical and formulation chemistry as well as small molecule manufacturing for early clinical trials for a subset of our key programs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Expanding Operations to Canada&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We announced our intention to launch our first major expansion beyond our Salt Lake City headquarters, with Toronto to serve as a multidisciplinary hub across data science, machine learning, engineering and computational biology. Additionally, we announced a multi-year collaboration with Mila, the Quebec Artificial Intelligence Institute, to accelerate Recursion's machine learning capabilities.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Second Quarter 2021 Financial Results</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Cash Position&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cash and cash equivalents were $632.7 million as of June&#160;30, 2021 and included net proceeds of $462.4 million from the company&#8217;s April 2021 initial public offering.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Revenue&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Total revenue, consisting primarily of revenue from collaborative agreements, was $2.5 million for the second quarter of 2021, compared to $186 thousand for the second quarter of 2020. The increase was primarily due to progress in our collaboration with Bayer.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Research and Development Expenses&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Research and development expenses were $29.6 million for the second quarter of 2021, compared to $13.2 million for the second quarter of 2020. The increase in research and development expenses was primarily due to an increased number of experiments run through the Recursion OS, an increased number of preclinical assets being validated, and increased clinical study-related costs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">General and Administrative Expenses&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">General and administrative expenses were $13.9 million for the second quarter of 2021, compared to $5.2 million for the second quarter of 2020. The increase in general and administrative expenses was due to growth in size of the company's operations, including an increase in salaries and wages of $5.7 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">million, equipment costs, human resources-related costs, facilities costs, finance costs and other administrative costs associated with operating a high-growth company. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Net Loss&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Net loss was $43.4 million for the second quarter of 2021, compared to a net loss of $18.9 million for the second quarter of 2020.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Other Corporate Updates</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Therapeutics Advisory Board&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">A Therapeutics Advisory Board is being formed to advise Recursion's executive team and Board of Directors regarding key research and development issues. The Therapeutics Advisory Board is chaired by Joseph Miletich, MD, PhD, who previously was Merck Research Laboratories' Senior Vice President of Research Sciences and is currently Senior Scientific Advisor to Merck's CEO.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Altitude Lab&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Altitude Lab, a healthcare and life sciences incubator co-founded by Recursion in 2020, announced the launch of its Investor Coalition to fund, mentor, and provide resources for Altitude-incubated startups in Utah. The Investor Coalition aims to collectively invest $50 million in Altitude's startups over the next three years.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%;padding-left:14.15pt">Equity Index Inclusion&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> In Q2 2021, Recursion was added to a number of equity indices including the CRSP US Total Market, NASDAQ Composite, Russell 2000, Russell 3000, and S&#38;P Total Market indices. These indices determine membership primarily by objective, market-capitalization rankings and style attributes.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Recursion</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning, and engineering. Our goal is to radically improve the lives of patients and industrialize drug discovery. Central to our mission is the Recursion Operating System, which combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets. We combine that with the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights. We are a biotechnology company scaling more like a technology company. Learn more at </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">www.Recursion.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, or connect on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Contact</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Elyse Freeman - Communications and Content Manager</font></div><div><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">InvestorRelations&#64;Recursion.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Condensed Consolidated Statements of Operations</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Recursion Pharmaceuticals, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:133%">(in thousands, except share and per share amounts)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> </font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Three months ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Six months ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Revenue</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Grant revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">49&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">186&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">111&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">246&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Operating revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total revenue</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,549&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">186&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5,111&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">246&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Operating expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">29,624&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">13,244&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">53,733&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">26,086&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">13,854&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5,159&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">22,791&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10,720&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">43,478&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">18,403&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">76,524&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">36,806&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(40,929)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(18,217)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(71,413)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(36,560)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Other loss, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(2,472)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(726)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(2,705)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(807)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Net loss and comprehensive loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(43,401)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(18,943)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(74,118)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(37,367)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Per share data</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Net loss per share of Class A and B common stock, basic and diluted</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(0.31)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(0.88)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(0.91)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(1.73)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Weighted-average shares (Class A and B) outstanding, basic and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">138,360,646&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">21,652,277&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">81,022,240&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">21,646,118&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Condensed Consolidated Balance Sheets</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Recursion Pharmaceuticals, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Condensed Consolidated Balance Sheets (unaudited) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:133%">(in thousands)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:133%">December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Assets</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Current assets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">632,738&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">262,126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Restricted cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10,232&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5,041&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Accounts receivable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">49&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">156&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4,616&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,155&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total current assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">647,635&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">269,478&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">48,549&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">25,967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Intangible assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,338&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,490&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Other non-current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">68&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">650&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">698,590&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">298,585&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Accounts payable</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3,196&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1,074&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Accrued expenses and other liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">12,710&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10,485&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Current portion of unearned revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">10,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Current portion of notes payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3,135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1,073&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Current portion of lease incentive obligation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">499&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">467&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">29,540&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">23,099&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Deferred rent</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,819&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,674&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Unearned revenue, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">11,667&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">16,667&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notes payable, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">9,423&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">11,414&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Lease incentive obligation, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,427&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2,708&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">55,876&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">56,562&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Commitments and contingencies</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible preferred stock </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">448,312&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Stockholders&#8217; equity (deficit)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock (Class A and B)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">930,431&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">7,312&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(287,719)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(213,601)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total stockholders&#8217; equity (deficit)</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">642,714&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(206,289)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">698,590&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">298,585&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Forward Looking Statements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">This document contains information that includes or is based upon &#34;forward-looking statements&#34; within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding Recursion&#8217;s mission&#59; research and development activities&#59; plans with respect to preclinical, clinical, and late discovery programs&#59; collaborations&#59; prospective products and their anticipated future applications or performance&#59; platform&#59; technology&#59; facilities expansion&#59; growth&#59; expenses&#59; our ability to obtain, maintain and enforce intellectual property and cybersecurity protections, and business and financial performance&#59; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;target,&#8221; and similar terms. These statements and their underlying assumptions are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Such risks and uncertainties include, but are not limited to challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure remains high and failure can unexpectedly occur at any stage prior to regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors&#59; our ability to fund development activities and achieve development goals&#59; the success of our collaboration activities&#59; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates&#59; the impact of the COVID-19 pandemic on our business, clinical trials, financial condition, and results of operations&#59; our ability to obtain, maintain, and enforce intellectual property and cybersecurity protections&#59; our ability to attract, motivate, and retain key employees&#59; and other risks and uncertainties described under the heading &#8220;Risk Factors&#8221; in our</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">filings with the U.S. Securities and Exchange Commission, including Recursion&#8217;s Prospectus for our initial public offering filed on April 16, 2021 and our recent Quarterly Report on Form 10-Q. All forward-looking statements are based on management&#8217;s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rxrx-20210813.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d5aea7c-67e3-4454-a7c1-467c78f28566,g:86614da4-bb51-4082-99bb-fc6637ee7a56-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rxrx="http://www.recursion.com/20210813" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.recursion.com/20210813">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20210813_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20210813_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.recursion.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rxrx-20210813_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d5aea7c-67e3-4454-a7c1-467c78f28566,g:86614da4-bb51-4082-99bb-fc6637ee7a56-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_a0d38158-92ae-4a02-a040-edaa97da535d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_847a9f19-e4b1-443b-b1cb-c752ba94f30f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5285fb19-3164-470d-82de-784ff24811c1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7f6be95e-1050-4e7d-9ce4-546846737572_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_50c4b15b-95b4-4688-8951-9eecaa715b56_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ba15a745-078c-4183-8a5c-a51bc1ca1ae8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_53f91fe1-298e-4b34-bfa6-0d70bfcab7f9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_da08ed2e-780c-4d0a-95b3-a87c3aa2ae0e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a461bb74-ea3a-44f4-8429-c2375ae1e422_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_df1867b7-4dd9-4395-ac50-df903d8c7053_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_65b830be-45b9-4b7a-a25d-83a4891091d0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0e54b7fe-2c20-401c-aaa2-b11e94de86f0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8d77181d-1f83-4dd3-be56-d8ac074f85a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_17cc8688-33a9-44ad-9d72-8ae087cfc10c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ab716be6-520a-4bf6-a358-a484bf070215_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_30f6038d-16d3-467f-830a-a41094655195_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_305f0db8-5661-4fd9-bf43-b8658e6b75b8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8ec80d23-a1e2-4387-850b-7bc5eb1c043b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_fe89ed81-ef32-4fb4-b903-3ff89dafc9cc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_28b00fe4-d607-4c79-8c87-772b5fa190fb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6084699e-4812-4f2f-8357-663e7aaff8c6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e242d1ee-cc53-40d9-9c3a-1a7d6b823561_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c445877a-889a-44e7-acc7-d7c173bdb6e8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_48b2e3d5-4350-4549-bb55-91599fabeb2e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_978f130e-dee8-480a-90fe-b19ad00658fa_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rxrx-20210813_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d5aea7c-67e3-4454-a7c1-467c78f28566,g:86614da4-bb51-4082-99bb-fc6637ee7a56-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.recursion.com/role/Cover" xlink:type="simple" xlink:href="rxrx-20210813.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2021dc9f-6e8f-4f42-8bf2-4ec930a258cc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_DocumentType_2021dc9f-6e8f-4f42-8bf2-4ec930a258cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_53be2029-6b0e-4cb9-a7c9-36dc8fe1aab8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_DocumentPeriodEndDate_53be2029-6b0e-4cb9-a7c9-36dc8fe1aab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_856acd56-56c1-4ae0-82db-de3aa996a998" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityRegistrantName_856acd56-56c1-4ae0-82db-de3aa996a998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_830fc112-d30a-4f9a-b917-77b446cdfef3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityIncorporationStateCountryCode_830fc112-d30a-4f9a-b917-77b446cdfef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8e31875b-3f8c-450d-a56b-f5977527ab52" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityFileNumber_8e31875b-3f8c-450d-a56b-f5977527ab52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_61d6c4b5-4371-47c4-8fbd-6b80f6d61da3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityTaxIdentificationNumber_61d6c4b5-4371-47c4-8fbd-6b80f6d61da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7f5d74d3-a18f-4f93-ba3e-b9a32f00a040" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityAddressAddressLine1_7f5d74d3-a18f-4f93-ba3e-b9a32f00a040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d6c15a6f-c018-4da6-91a7-67a1ef648a38" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityAddressCityOrTown_d6c15a6f-c018-4da6-91a7-67a1ef648a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_917f87e4-57ce-4f6d-a1bf-40b74dfd0f38" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityAddressStateOrProvince_917f87e4-57ce-4f6d-a1bf-40b74dfd0f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e55a510d-6c29-4e1c-b676-94d258ee86a5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityAddressPostalZipCode_e55a510d-6c29-4e1c-b676-94d258ee86a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2014999f-2ea6-4676-ae09-0e1dc6be0cca" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_CityAreaCode_2014999f-2ea6-4676-ae09-0e1dc6be0cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ca6ddcb2-e08b-4fca-bd12-8d9cd34dd463" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_LocalPhoneNumber_ca6ddcb2-e08b-4fca-bd12-8d9cd34dd463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_48a96943-40e7-4947-8302-d8abb4b1c536" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_WrittenCommunications_48a96943-40e7-4947-8302-d8abb4b1c536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_9619180f-ceae-4c6c-a4e5-379e08422a30" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_SolicitingMaterial_9619180f-ceae-4c6c-a4e5-379e08422a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_61e2de86-bfaa-4c9c-88a5-0b167f4a3d28" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_PreCommencementTenderOffer_61e2de86-bfaa-4c9c-88a5-0b167f4a3d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_15081aa0-1c1d-4f54-9310-40c682bb494b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_15081aa0-1c1d-4f54-9310-40c682bb494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ebb5dfb4-88c9-4577-81cd-9a33c604379b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_Security12bTitle_ebb5dfb4-88c9-4577-81cd-9a33c604379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_54e6cd5f-6cb6-4c21-a927-571b1970a848" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_TradingSymbol_54e6cd5f-6cb6-4c21-a927-571b1970a848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_586837fc-b8c4-4f0c-8666-0975e5fb3aa1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_SecurityExchangeName_586837fc-b8c4-4f0c-8666-0975e5fb3aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_897d3850-465a-4f58-94c9-8f616e0f9152" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityEmergingGrowthCompany_897d3850-465a-4f58-94c9-8f616e0f9152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_84487de0-2faf-4bc9-811c-2b68924f56f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityExTransitionPeriod_84487de0-2faf-4bc9-811c-2b68924f56f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fe3a2751-47d3-48c9-bd0d-80cb30e9ad52" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_EntityCentralIndexKey_fe3a2751-47d3-48c9-bd0d-80cb30e9ad52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f28fb593-2d98-44b6-a95d-6b69265fd9a8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_AmendmentFlag_f28fb593-2d98-44b6-a95d-6b69265fd9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_538cbf48-7c90-4814-a80d-3a188ed63b81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_DocumentFiscalYearFocus_538cbf48-7c90-4814-a80d-3a188ed63b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c5ccd990-75ba-4348-9947-8231e13975f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15a996fb-f4a0-4e9f-8dc0-55d93fc355aa" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c5ccd990-75ba-4348-9947-8231e13975f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>rxrx-20210630_g2a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rxrx-20210630_g2a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (< \ # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH JZA>_885DV;\MMQG'8_X5G_ /"1?].__C__ -:I_$'_ !YI_P!=
M!_(US]-$-LV?^$B_Z=__ !__ .M1_P )%_T[_P#C_P#]:N1\2>+-$\&Z=_:&
MOZQI^AV&]8OM6I726\6]N%7<Y R>P[UIQR+-&KHRNC#<K*<@@]"#3L*[-O\
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M1I,I,NT444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "F>='YGE[U\S&=F><>N*))!%&[M]U06/X5YLNI2C4OM^X^
M9YF_\/3Z8XJXQYC>G2=2YZ9138W$D:NO*L,BG5!@%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%4-6UB#1X-\IW.W"1KU:N)U'Q)>ZBQ!
ME,,1_P"6<9P/Q/4U+DD=M#"5,1JM%W.]GU"UM?\ 77$49]&< U3;Q-IB=;M3
M_N@G^0KSOW[T5G[1GJQRR'VI,]"_X2K2_P#GZ_\ (;_X5)'XCTV3@7D8_P![
M*_SKSFBCVC*>6TNC?]?(]3ANH;A<Q2I*/]A@:EKRA6:-@R,4;^\IP:W=+\77
M5FP2Y)NH??[X_'O^-4I]SDJY;.*O3=SNJ*AM;N*^MTFA</&PR"*FK0\=IIV8
M4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,
M\0?\>:?]=!_(US]=!X@_X\T_ZZ#^1KGZI&<MSY3^*?Q!\0^'O%%U\7CX&TSQ
M'X0T<W/A&"QN=2$>H"Y;4?LAN8U:%HTCDF41$;]WED.>ACKU/]GG1O$G@?P]
M=^#O$FF:78S:?))J%JVC7CSVRP7=U<RI;J'BC*"#'E  ;2JH1MY5=?6/@#X$
M\02WIU#1'NK6]N7O;C36O[D6$EPQ+-,;42>3YA<E]^S=O^?.[YJW_"?P_P!&
M\%37D^F+?/<WB11SW&HZE<WTK)$&$:[YY'8*NYS@$#+L>I)((/B-XDN_"'@;
M6]9L+:&\OK*V::"WN'*1R./NJS $@$]2 ?I7#)^T-8Q_:A)H>L7UU'=26PT[
M2K)[JZA:*WBDG21$S\R/+L^7()*XX.ZO5KVQM]2M9;:[MXKJVE&V2&9 Z./0
M@\$5F:AX+\/:LTK7V@Z9>M+<"[D-Q9QR%YA&(Q*<KRX153=UV@#H*8'.^&_C
M)HGBKQ)_85G;WZ:BN?,CFB5?+VJQES\W_+-PL;8SAY$'(.1B7/Q,\0V::)>F
M+2;JWUJ^$%MI<6Z.\AC#E&R6DVR'H6;"",X7:^X$>D6F@Z9I]R;FUTZTMK@F
M4F:&!4?]XX>3D#/SL S>I )YJG;^"?#MKJ4VH0Z!I<-_-*)I;J.SC65Y 20[
M,%R6RS').<D^M ' :-^T;I/B&2S73_#GB26.\D$%O</8B.W:7Y04,Q;RP07(
MP&)/ER8! &9A\>]-:&UG?3=1M1+%!,MK)%$\LRSIN@ 99MJ$M\ISD9[@?-7;
MVO@3PU8WHO+;P]I5O=C9BXBLHED^0 )\P7/RA0!Z #%22>#= FA:*30]-DB:
M$6S(UI&5,04H(R,?="L5V],$CO0!PWBWXWQ^'9TT_P#L>\AU.9FACDE6.:V2
M95D?9(\4AVDI$S!20V&7C[VW<\1^*M6M?B!HV@:>8(K>XM7NYY9+&2Y8A98T
MV@K(@C&'/S-N[<5I)\-?",=Q!<)X5T5;BW3RH95TZ$-&GS?*IVY ^=^!_>/J
M:NZMX2T/7KZTO=3T73]1O;3/V>XN[6.62')!.QF!*\JIX[@>E '$6OQN@U/4
MK*TM-#OXH[J)YA=7#0X2,)<%7V+(2V6M9/ER."ISDD!]K\:K6.S274-)OHO.
MO5T^U>$1L+J9H8I(U"[_ )&?S3A22!L.6KLSX/T%F@8Z)IQ:#_4M]DCS'C>!
MMXX_ULG3_GHW]XU!)X'T=KZSN8;.*T^SW NS%;0QQI-*L7E(\F%RQ1>%YXP/
M08 -ZBBB@ KIM'_Y!L/X_P#H1KF:Z;1_^0;#^/\ Z$:3*CN7:***DL**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.\1
M3&'1;M@<$IM'XG']:\ZKN?&4FS1B/[TBC^O]*X:NFGL>EAE[EST;P_,;C1K1
MSR?+"G\./Z5H5B>#Y-^BH/[KLOZY_K6W6$MV<-16FT%%%%29A1110 4444 %
M%%% !1110 4444 %%%% !1110 4UV$:LS'"J,DTZLSQ),8=$NV!P2NW\SC^M
M(N$>>2CW.%U747U2^DN&/RDX1?[J]A52BBN8^VC%02C'9!117#_&CQ)KWA3X
M?W.H>&%L9->^VV%M:1ZBX2"1IKR&$HQ)'+"0J.1R1R.M 2?*FSN**\>NM)\?
M>%?!R>)IO&VH7^MVUL;JX\.:I;:>+*XDV[FMD>"!)4)(*1OYCX)!82=#ZEX@
MT^35M!U*RB*K+<VTD*%\A060@9]N:!*5^A?HKPZ]^!NMG5-/D6XT_4=/L7B$
M,-TR;UB6,#RV,MM.K8.X @*VW;\P.2=6[^$FKZYI=OIFH2:=;VUJT"1RQD71
MD2-YVW-%+#L!/F1_*=P^]\W )".>7\I[UX1U1K34!;,?W,_&/1NQ_'I^5=U7
MQVGP/U231HK"3^S()Q%Y<VJ)(9;BX3]WB%P\.&1 I"[MRGRTR@R<>@>-OV<]
M3U3R(M%DTN>SAMO)B-ZL%NZMY;+YFR.S:-3N;/[I8SUVLAK:&Q\_F$+34[6N
M?0E%?.V@_L^W5G;O/ ?#_B:TN;8H]K=,D=L;@^;^^'EVY#NA8!7<,^)'!;Y5
MSHP_ WQ5I=V\EGJ^GW</]J1ZX8;J24&:^C9461VVL0K0K@J,X=5(SDFM#RCW
MBBO&-'^!-VOA&VT+Q*^A>*/LNL0:E#=3:>8QM,B27*F-S+AG=9')#88RG(4"
MH9O@?J$MG=6[V.BOYD<<<TBS;6U.19F?[5<A[9T,@'.UTE&7;E< T >VT5XI
MI/P=UVRU+0K^XM?#\MW9W<<\CJY,<"_N1(L,;P,0<(^TH\1R$#%E^4;/B;X+
MP:EK/B?6=)@T_1]=OK>W^P:M:Q+%=0W"-*7=G$9.'#JK==PW CI0!ZE17SSX
MD_99AN+02Z.MC;7D.H-)#;[+9(3:DC:KO)9S%V554!9%D0<X&<$>A:9X%U"V
M^(6EZN^CZ+;:?9Z:EK]IM;@B[,FS:591;JK1* %10R*-S,4SM"@'HE%%% !1
M110 4444 %%%% !1110 4444 %%%% &9X@_X\T_ZZ#^1KGZZ#Q!_QYI_UT'\
MC7/U2,Y;GE/C7QWXW'Q8M/!/AO2(;&RN=-BO_P#A*M2TJZOK*&3S)P]LRQ/&
MN\K$A!:5 -_1B54]%X#U[Q)+JVK^'O%4-C-JFFPV]RFJZ3$\-I>PS&55(A=W
M:%U:!PR%W&"C!SN*K7U[PKK^F_$0>+?#0T^]:^T^'2M4T[5+F2W1HX99I8)H
MI$CDPZFXG#*4PX=?F79\T?PY\*^+-+\5>+-<\2ZE&\.K-;BRT>WO9+N&P6,R
M[MLCQ1GY]ZD@* -H'."S,1WDUQ%;JIEE2(,P12[ 98G  SW)[46]Q%=1B2&5
M)HR2-\;!AD$@C(]""/PKD/BQX%NOB+X7AT>UU*?2";ZVGDO+601SQQI(&?RV
M*, Y4$ X[]0>1Q6H?"OQI<62?8]7M=)FMVMXH;73M0N;:U^S1021M$B(H$(D
M;RS\JDIU!8HN0#VBBO(=4^'_ ,0KBRM'TWQ'!I-Y&]S<-;_;)YX%<2E[2')4
M%X@'<2'"D@(H!"C&KH/PUUK3[N]6[UZZN[2XM[VUWSW\\[[)/)%NQ5_EW(J2
MY(Z&0XSN)H [33?%FAZS)Y>GZSI]])YLD&VVNDD/F( 73"D_,H(R.HR,UJUX
MWJGPN\4>(/L,DT6B:'/INF2V-I-I5[<+,9/(9(G:18T(17;(CP=O)!8G S++
MX,^._+O1>^,+^YDDM[B-6;7)@C3%)/)F5(X(VC(9U)4O)M"(%/R#(![E]JA^
MT_9O-C^T;/,\G<-^W.-V.N,\9HN+J"T$9GFCA$CB-/,8+N8]%&>I/I7E5Y\.
M/&$-],UEK"SZ6MZ9XM-GU6YB$L)*'RGE"LR#=O;@-GA?NL<4['X8>-6\>6&I
M7FJ0#1+<QLUD=6N;I69&@*L$EBR&4)*-QD;<7SA-S"@#U35/$VCZ'=6MMJ.K
M6.GW-V=MO#=7*1O,<@80,06.2!QZBM"21(8VDD94C4%F9C@ #J2:XGQ)X9UZ
MX^(FC:]I?V5[*WLY+2YCEO6MW.Z:-P0!!('&$;C*<XY[CE;+X3^)[76-)U";
M5_MDMM&WF--JMTQ65DNU:1 003B:W&..(R.-JY /7X9DN(DEB=9(W4,KH<A@
M>00>XI]>-?\ "OO$NESV=I%J=U!+J&KK->7%G=7$JR6OV6(7!D+ "-R\.$;)
M/S\8RV/9: "NFT?_ )!L/X_^A&N9KIM'_P"0;#^/_H1I,J.Y=HHHJ2PHHHH
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M4 %%%% !1110!S?CA\6-NO\ >ES^0-<;74_$*ZBM+2WEGE2&&,/)))(P544
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M?,..N,?5_P!HGP_I)DSIVI3B#S$NF5K6);::,$S0.TLZ R( I*J6R'3:6SP
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MK4F@[])M+:#19Q<6EM;6D*(C"59AM.S<@\Q%<^65R1\V02*[*B@# O\ X?\
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M\"IZ* (/L5O_ ,\(O^^!1]BM_P#GA%_WP*GHH @^Q6__ #PB_P"^!1]BM_\
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M,D_YY'_OH4>9)_SR/_?0H EHJ+S)/^>1_P"^A1YDG_/(_P#?0H EHJ+S)/\
MGD?^^A1YDG_/(_\ ?0H EHJ+S)/^>1_[Z%'F2?\ /(_]]"@"6BHO,D_YY'_O
MH4>9)_SR/_?0H EHJ+S)/^>1_P"^A1YDG_/(_P#?0H EHJ+S)/\ GD?^^A1Y
MDG_/(_\ ?0H EHJ+S)/^>1_[Z%'F2?\ /(_]]"@"6BHO,D_YY'_OH4>9)_SR
M/_?0H XCQ<V=<?VC7^M8M:OBIRVN3Y4@[5&,CTK)W'^[77'9'LT_@1N>#VQK
M0'K&W]*[NO/_  H[+K<6%R=C#&1Z5W?F2?\ /(_]]"L:FYP8CXR6BHO,D_YY
M'_OH4>9)_P \C_WT*R.4EHJ+S)/^>1_[Z%'F2?\ /(_]]"@"6BHO,D_YY'_O
MH4>9)_SR/_?0H EHJ+S)/^>1_P"^A1YDG_/(_P#?0H EHJ+S)/\ GD?^^A1Y
MDG_/(_\ ?0H EHJ+S)/^>1_[Z%'F2?\ /(_]]"@"6BHO,D_YY'_OH4>9)_SR
M/_?0H EHJ+S)/^>1_P"^A1YDG_/(_P#?0H EHJ+S)/\ GD?^^A1YDG_/(_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYC#%O*LQ+R!6*C:C=%.3@=ZPX?B-(='U6ZETV-;FQ-M%Y,5V)(WFF" #S N
M@=P"^#P"<=J%%M7071ZSI<GF6,7J!M_*K=>3:3\4]7C:VLF\/V<<WVU[*ZFD
MU&7[-'-O5459%MF^]O7F01 D[5WGBLR7]H#6;"YLX;[PG:JUP[K_ *'J4\^
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MOEQRH/457N_AKX0U"Y>YNO"NB7-P\GG---IT+.TF2=Y)7);+,<]?F/K7244
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M2-S,@^UM(K%1\OF0HN67YB.:]>\7:AK&GZ=$^B6*ZA>-,JF)^FS!+<EE /&
M20,D5CZ'XD\>QS137/@^"1H_E>*"]3YRS$ JVXX !7J.S$X%:X:"J2C!J]V1
M4?*FS)@^/&L7FFKJ,/\ 9<(*DPZ5<6TJ7=W&4E87"9D!6--F&4H3F*3)7MUD
MOQ)U'7)?#2>&+G1]3MM;Q =1C<7$-E/&OG3*ZI*"^Z(,%4$%64%B0W'5>%]5
MU[4'=-:TB/2W2)6/ES>:&8DCAAQV/R\XXY.>.AK[@\8\2A^+'BBRCLH=4OM
MMS>33QG5&L98;:R5+IH%:5&N3NW% H^=?FE0=N=S0?B=?7_C30=*N-2T6>UU
M"T21?L,3-)/(87DWKNF#QHP0LN8G7:#^]W$"O4:* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOY4 245']GC_ +B_E1]GC_N+^5 $E%1_9X_[B_E1]GC_ +B_E0!)14?V>/\
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M8;2MQ;0N,E#\VP@Y!!-9'&>ET5R%U\0/LMU%#]@W>99VEWN\[&//G$6W[O\
M#G.>_3CK6#>?'32M-NO UM>K;6=SXHD9$AFO55HEW"-2@(S*QEDB7:,<,[?P
M$$ ]-HKR3PS\<+_Q/#,D'AR.&]:YAMK1)KN:.%VD\X_O)'ME*X2 G*+(I+*
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MR D*O(VC&[X1\)V?@G1AI6GRW<EDDLDL:WMR]Q(F]R[#S')=AN9CEV8\]<8
M -JBBB@#'UZ/YHI/4%:HZ?'YM["O;=G\N:U=<3=9@_W6%4M$3=>%O[JFOE\1
M2OCTN[3_ *^X].G+]PWV-ZBBBOJ#S HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6N:E(UMX=^%^J7>IZ9H2:_K^FZU>KIESIT;22(((U:-_.F/DRLH)C1E"G?\
M,*DNOVP]%M;/Q3J3Z0RZ)I_@RW\:Z1>276UM5MI0X,10I^Z=9!''U?F0=.A
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MP;H&L/&]_H>FWKQ[2C7%I'(5P,#&1Q@<"K^IZE;:/837MW)Y5O"NYVVEC[
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M@@$,"<J0%T/XE^'?$L:MIE])>%H);CRH[6;S%2,J&W(4W*WSKA2 S Y4$ T
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MJEK');^'QHFN);Z4L UF1'#PW;;7/ERJ3("3OW*X!/R@U[]10!P7P7^%-O\
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M^Y_6O KO_A0I^G^9W0_W>7]=C<HHHKWSA"BBB@ HHHH **** "BBB@ HHHH
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MM6_7+>.IL06D6?O.S'\!C^M3+8Z\)'FKP7F<?S[4<^U+17.?7B<^U'/M2T4
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M+_=3_OH_X5)10!'F7^ZG_?1_PHS+_=3_ +Z/^%244 1YE_NI_P!]'_"C,O\
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M_P 4/B8WAWP7)KFF^-/!=KX9M]5DU"U@M;*;S+H2R3J\GG;46=6'EQ.6(P*
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MRPPQ.-WS5Q6K>$?&=]8I!I:ZMI<4"R3?Z9K,LT\LAA0!=RW74,#MW,8]V24
M.3))HOQ+O([YY UG+/J<6J6GDZKO\M4WG[-,,*$0A8%9(RZDF5MV6H$Y7>L3
MV:DKR+2]#\:KK5G?:C#J<[/J(N7MUU("W@BD,19/EG7(CRX"E)%8(<*I;<?7
MJ1K&7-T/2M%N?M>DVLO4F, _4<'^57JYSP1=>9I\L!/,4F1]#S_/-='72MCX
M_$0]G5E'S"BBBF<X456U*\.G:?<W2V\MV88VD\B J'DP,[5W,JY/N0/>N*\4
M?&32?"OA_1-8N+&]FMM5M6O(U22VB:*,1K(=YEF1<X8?*I8DYQF@#&_: GUJ
M'P3J+:#]N%V)K);AM,0O=K9&ZB%XT"J"QE%L9R@4%MP7:"V!7+_!R$Z?XI\1
MVNEOXJD\)Q6]B]HWBIKZ247A:X^TK')?9N&3RQ:DY)C#,0IW;P+-G^T-HGBF
MZNCI>D:M>W$:&;[+$UJ9/)4$.[?O]J;2HRCE9!O7Y>>+5]\9-*L;&^U Z??R
M:7;1&5+[=;QQW&&12J"257&"_+.JK\K?-TS\7B'+VLU;J_S/8IVY5Z'ME%>=
MZ5\<=!U2&V>."]!EL+B_Z1.JK"SKLWI(59G\F9D*EE98G.X<9T?!_P 5M&\;
M7]A9Z?'=+/=Z4FK%9T5?(1G"&&0!B5E5CAEYQ@Y/3/VAXYV=%%% !1110 44
M44 %%%% !6%XA\1#3U-O;D-<D<GLGO\ 6F>(/$@LMUM:L&N.C/V3_P"O7&LQ
M9BS$LQ.23U-1*71'GXC$<ON0W!F+L68EF8Y+'J:2BBLCR@HHHH Y7QMX\3PE
M/I^GVFE7GB'7M1$CV>DZ>T2RR1Q[?-E9I71$C3S(P69AS(BC)8 ^'36^G-H=
MWX=GO/$UIIDU]_9TGPL\FR:>>69'G^R1W _Y='C$LA(EVA$==Z*C1CVSQEX)
MOM:U[1O$.AZK#H_B#2XKBTBFO+0W=O+;3F)IHGB$D9.6MX&#*X(,?<%@>8E^
M"E]=7S>)+CQ% WCQ=0CO[?5H].*V<0C@EMU@^RF8LT1BGGR#+N+2%@RX4*S6
M+21PVH:@EC-XD\_5?%/PV>YDCO+_ ,)PQ65S-?274@A5[&9?,VM/+B-@K@J[
M;L1EQ(R>9;>%;RX*R:Y\"T721+);O'I][:7EG91+'OC*F94GBB\M<=60+\L@
M3Y.ZU;X)WWBVYO=5\1^(H;GQ&$M5TN\TW3C;0:>;>X6YC80O+(9"TR(7W/AE
M4* O)+]<^#%]\1))?^$\UVTU:!=/N;&U@T73GT]8&N%"R3DO/,6D"J G(5<M
MD,2"K*YE_7]?F<)I]C%H^I:%'9V/B3X17%Q;MIUIKFH&QNXM40&6Y\N[4O(4
MFRUQ,K.$.YY06)8HW2?#7QS9^&M/LBOAOQ'_ ,([KMZDJ>,M3-LW]I7-RZI%
M/+%&_FQK*QC5,Q*J@Q@J@P!T%S\+]=\676DQ^-O$6GZ]I&FR-<)9Z?I#V+7,
MWE/$KSN;B3("R.=J*GS;3T&TPZ7\*O$=MIFA>'[WQ=:W?A;1Y[66"&+23%?S
M):R));QRW!G9#AHX]Y6%2X4_=R:0G)/<]0HHHI&(4444 6+&^FT^X6:%MKCJ
M.S#T-=[I.K0ZM;^9'\KCAXSU4UYU4]G>S:?<+- VUQ^1'H:J,K'31K.D[/8]
M,HK/T?68=7AW)\DJ_?C/4>_TK0K8]J,E)704444%!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 4-:O/L6GR,#AV^1?J:XNM
M7Q%?_:[SRU.8X?E^I[FLJO7P\.2&O4\+%5/:3LMD%%%%=)R!1110 4444 ;7
MA>\\FZ>!C\LHR/\ >'_UOY5U->?1R-#(KH<.IR#[UW-C=K?6L<R_Q#D>A[BO
M,Q4+/G74]?!U+QY'T+%%%%<1Z(4444 %9^L:Q%H]OO?YI6X2/NQ_PI-9UJ'1
MX-S_ #S-]R,=3[^PK@;R]FU"X::=MSM^0'H/:M(QYM6=-&CSZO82[NY;ZX>>
M9MTC=?0>P]JAHHKI/4VT04444 %%%% !1110 4444 <9XPO]5TO5+N>&XU8:
M8-)FE,>FV*7,B3K)'M\H>6Q:1E9P%;*\9QP36+?3>-=8T#PVFE:A<6VH3P7#
MW5Q-;"W < >6LOFVS%<$XXC3?@D;0<5Z;10*QX9I>L_$:&-TUR[U:WA>V\];
MFPTU+B7SL2;(P@M<(C;>5*NRE4^?#C.KJ6N>./L]X(O[536)E,:VD-E&+.U.
MZ+#K*8'W94MR7< LWR?+QZ]12L+E\SQ>Q\7?$**[$%QI.K2VT%K=6TUX+6%E
M^U$RM$WW4>3:$A4/'%Y3>:Y.-HJ./Q'\0YH88;H:A8&VLUMIKB+3MQNKE'CW
M3J5@E\M9%?@!&"XD&WC<OME%%A<K[E#P_=37N@Z;<7"7$<\MM&\BW<8CF#%0
M2'4 !6SU  P<U?HHIEA1110 4444 %%%% !1110!/9WDMA<)/"VV1?R(]#[5
MZ!H^KQ:O;"1/ED7AX^ZG_"O.*L6-]-I]PL\#;77\B/0U$H\QA5I*HO,].HK/
MT?68=7@W)\LJ_?C)Y'_UJT*YMCRFG%V84444A!2=*6LSQ%??8=(G<'#L/+7Z
MGC_&@N$7.2BNIP>IW7V[4+B?J'<D?3H/TJM24M<I]M&*BE%= HHHI%!1110
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MC>O]X?G0 M%)O7^\/SHWK_>'YT +12;U_O#\Z-Z_WA^= "T4F]?[P_.C>O\
M>'YT +12;U_O#\Z-Z_WA^= "T4F]?[P_.C>O]X?G0 M%)O7^\/SHWK_>'YT
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MJ^&5",9<U[W^5OZ^1U4:[K2<>6UK?B7****XCK"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#+\0>*=%\)62WFN:O8:+:,XC%QJ%RD$98]%W.0,\=*T89
MH[F&.:&198I%#I(A!5E(R"".H(KR+XJ6<NE_%3PCXGOM"O\ Q!X>L].O[.2+
M3[%KV2VN)?**OY* L0ZHZ;@"!GG ->36_@CQ[I?A73=.B7Q-I$$'AG6K^VL=
M)N)XQ;W)N1+96[&(X,BHP41Y/ *C(R*[(T(RBGS6_I_Y?B>E3PL*D(RY[-_\
M'\K?C]_US67XB\3:;X4L8KS5;G[+;27$-HC^6SYEED6.-<*">691GH,\X%>!
M^"KCQM>>)IY]=3QC'XHDV/IR0)(FBK;FP0@7*O\ N0?/W[@/WV_&/EKE8-)\
M=:MI>FPS6OBR_17T6;6H]:BGDVZFFH1-,UL''^J5 Y8Q?N@ A'>JCAE?678N
M."7-:4U;3\3ZZHKY.UB;XJ6=KKMQ83>(HO$T=OK#ZJ]\TBZ4D(8FS-F7_=!]
MFW;Y?/WO,YK"O/%GB'2X_%&N>$M<\47,6CWVFVEKI6OWUQYL[75JT+1E)VSO
M$TD<@##^'(X(--81RVDOZT_'IY%1RYRVFOZ=OQOIW6I]G45C>#=&N?#OA/1]
M,O+ZXU.\M+2*&>\NI6EEGD50&=F8DDDY//K6S7"]'9'DR23:04444A!1110
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M[9[J%+5KDR*8 GF>8OS#;C.1CKQ46E:I;:WIMM?V4OG6ES&LL4FTKN4C(."
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MLADD:)P5,JE<2(4!5),'E@%^:O8Z**QJSA.W)&UC:G&4;\TKA1116!J%%%%
M!1110 4444 %%%% !1110 4444 (V=IVG![$C->:Q_$C5(]8\/6$Z63M>S21
M3LD93.VX>(% TNX<)GY1)@GYMBD,?2Z*N,DMU<TA)1O=7."UGQ1KNEZ_?VS7
MNE0Z>AMU2XFLY +;S3)AI6\X!A^["<!<M(IR,8--O'VLVL-OJ,[64M@VF37G
MV:WLI&FN)%=(XUB82GB1G4J-K'#  G.:])HJN==C15(]8G">$_B5'JUU86>I
M3VMC=SVHS#,CVTKW(E9&58I2' . P4C=AAGK61K?CCQA:ZA)]AT^UN-/-_+9
M(ZV@=UVGC -RF]B W&$ QU)P#ZE13YXIW4052"E=1/)H?B5J&K:3FZ71YENK
M=UGT\Q-(;9-J9GF^<[H2'W;=J_*RC?W.+%J&D^'9-*M;+0/#*Z+IET+J:YM-
M'BAM[:8S&,S1D3$1,$XWJ)"6X.W.*]SHJE52V1HJ\5M'3U/&]/\ C7J]Q=/%
M-I0A?R&46\UI/!,EQ(V;4,LF"(RH*,^,%URIQTZCP+XZO/$>KBUO)[ E[);E
M(+2/YEXCW;F\UB.9!\K(O489\$UWE%3*<6M(V(E4IR3486"BBBL3F"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#BO$/B[4-'U#4H#/86]O$;<QW5Q$VR
M!764GS/W@W9:(*""O+C@]UU;Q)KL-KX?O+..U"WL)DGL9+9WF9A TI1&$B[2
M=NT94X)SSTKM**RY'W.]8FFK?NUI^.ENW?7^FWYU'XQUV^L]UCJ6BW.V\M8#
M=Q6<DD+"8J"H GX9-V3\W.Y>!W98_%I9;NX^U^5860OTCAN;R&2WCDM6#J)%
M>3"OEH]VY<KMD0=:](HJ>2721M]:H--2H^FJ7:_V?^&.$\9>+M=L;ICX?AL[
M^WCL%O6,D8<.I<C._P Y,+M!.0KD^E8FG_$S79/,COET^RN(6CQ;S0%);S=Y
M?[J-1.P5QO!SE\AT.T=*]6HH=.3=U(*>,HQIJ$J*?GU_+UZ=?)'F-W\1=86/
M9:-97=]-*@6SM[0O);KND#(X-PNYQL Y\OD-@'H,IOC9J37%HL%C#+'+Y'[P
M6TWES;4#W2PR_<=P"0J@DAHGW9&,>QT4G3GTD:QQN%7Q8=/YV_3^M>YYEIWQ
M.OK_ %2U5WL+6QN+X0Q(T9:>2%S'Y1P95()$BY*J^"PRJ@9/IM%%:1BX[NYP
M8BM3JM>SARV_KL%<]I>M7FI1ZJBR6PEMGQ%*L6Y",9Y D.>F.JGU4<9Z&BIJ
M4Y3DFI62O\SGC))/0Y&Q\2:E,UE'+-9">98OW(A8,^]-WF*/,^ZO0CG.QN1V
M9'XNO+673X[L1SF:>03R6]K($BC$AC4D[F"Y8%MS$#"L.O-=C17']5K):57?
MY^7GY6^9M[2'6/\ 7W'.+XG-UX;DO+26VFOH]JO&AWA&+[<%=P(^A(K'D\7:
M]97DD5W:V\2+)Y?F-%A0"I8.Q$K8P,,5 / /S \#NZ**F%K3Y7[5IJVVS^5P
MC4A&_N7.17Q7<AU$ES9")'(,RQ,1=#>%/E#S.",X/+<D<=JS_P#A/M1MXSY]
MH'E8I(D<-L[-Y.7+MM1W)&%"AC@!FY'%=]142PM=_#6:^7_!_K?5C56'6']?
M<<%JWCZ^LUN4ACM-XNU$,TF?*^S%E0L3N +ACZ@8*].376Z#J!U32X;EG21V
M+!FC7:N0Q!P-S>G9B/0UH45M1H5J=1SG4YE;:W_!(G4A*-HQL%%%%=Y@%%%%
M !1110 4444 %%%% $%\TL=E.T#(DRHQ1I%+*#CC(!&1^(KEM'\8S:CKFF6+
M7FGF6YL([N:T4%98RR9!!+G.3G"A>%4DMT!["B@YZE.<I1E&5K?C^)P-YXLU
MK3YKY+J^TF"**>2*.ZEM'2,;(D?8<S<LV_CD8$;<'/!JGC+6M+74)&6W=O(M
MS:6<=A-),)9BW#!7+.$",2%4$@'IBN^HIG*\+5UM5?EOY^9S/AOQM:Z]?2VQ
MGMX9FCBEAM7;;.0T89@4)SE3D'CC!STKD[KQ[XLM88+G[#9M:30R3K*+<<!,
MY'_'QG:!M)<@$9X0\X]2HH"IAJU2"3JM-7U2M^IY_#X[U&?CS]-C,NPLYC8C
M3R79?+F_>#<QQM!S&,^M4Y?B=J%K<"9H8;K3A&%$D-N09IC"S!$/FL=S. %4
M(<@\,:],HH)>%KV5JSNO+_@_UZ:'E,'Q:U1K>]#6</VF-$CB#6\L6)D&ZX$B
M.0R#9AT4X.,Y[5V/A'Q)/KEWJ<%Q/:RO;.NU;5>%4EP,L';)^4CD(W!RHXKI
M:*"J.&KTY*52KS)=+6[^?G^ 4444CTBAK6@:7XDLOL>KZ;::K:;@_P!GO8%F
MCW#H=K C(HM=!TRQO!=VVG6EO=^0MMY\4"K)Y*G*Q[@,[0>B]!5^B@S]G!RY
MW%7[]0HHHH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** ,?7O&6@>%7@36M<TW1VG!,2W]W' 9,8SMWD9QD=/6M
M*UO+>^B,MM/'<1AVC+Q.& 96*LN1W# @CL0161K^AW&KZUX<N4>-;;3;R2[E
M5B=SDV\L2@#'K+GMTKQEO@+XTMY+5+/Q3=6-E)$K7UOINLRVQ:Z=YY)IT+P3
M 8:<A5"KG:A)4HHH ^@Z*^?O&7PT^(NG>'-/DT76))[RQMY+ZZDAU>Z$]U>L
MYE>,(T;AXB5CC0;HBJEA]TE"O_"F_B--=+,/%5QI\:H#!:VOB">5()D1!YCM
M+:LTXE:,,ZYBVAY "V\F@#WNZNH+&UFN;F:.WMH4,DDTK!410,EF)X  YR:D
M!SR.17BVE_"_QQ<:E+J&K:G;QW9M6L8&M]8NIS:Q-]C1RI:),NRV\KYP,._?
M)8=!I/@_QC9^#]:L?[2M[3Q!>!8(]8:_N+P8+'?=>4ZJL<@#L5B0;?D12Y4#
M: >BVMU!?0K-;S1W$+$@21,&4X.#R/0@C\*EKPK2O@?XLT?0;[3;?Q#!:+:V
M\T&C_P!DW$]DB^=<F:9F0^8L;[#Y:/B4IN9ASP=+P;\-?&^B^--&O=1UV6?1
M+!)-\;ZU+<R3[TD_=R1_9HT8+)*=K*4&V*(%"4#  ]CHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Q?\ A(O^G?\ \?\ _K4?\)%_T[_^/_\ UJQJ*JQG=FS_
M ,)%_P!._P#X_P#_ %J/^$B_Z=__ !__ .M6-118+LV?^$B_Z=__ !__ .M1
M_P )%_T[_P#C_P#]:L:BBP79L_\ "1?]._\ X_\ _6H_X2+_ *=__'__ *U8
MU%%@NS9_X2+_ *=__'__ *U'_"1?].__ (__ /6K&HHL%V;/_"1?].__ (__
M /6H_P"$B_Z=_P#Q_P#^M6-118+LV?\ A(O^G?\ \?\ _K4?\)%_T[_^/_\
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MHL%V;/\ PD7_ $[_ /C_ /\ 6H_X2+_IW_\ '_\ ZU8U%%@NS9_X2+_IW_\
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M_P#6H_X2+_IW_P#'_P#ZU8U%%@NS9_X2+_IW_P#'_P#ZU'_"1?\ 3O\ ^/\
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M /UJQJ*+!=FS_P )%_T[_P#C_P#]:C_A(O\ IW_\?_\ K5C446"[-G_A(O\
MIW_\?_\ K4?\)%_T[_\ C_\ ]:L:BBP79L_\)%_T[_\ C_\ ]:C_ (2+_IW_
M /'_ /ZU8U%%@NS9_P"$B_Z=_P#Q_P#^M1_PD7_3O_X__P#6K&HHL%V;/_"1
M?].__C__ -:C_A(O^G?_ ,?_ /K5C446"[-G_A(O^G?_ ,?_ /K4?\)%_P!.
M_P#X_P#_ %JQJ*+!=FS_ ,)%_P!._P#X_P#_ %J/^$B_Z=__ !__ .M6-118
M+LV?^$B_Z=__ !__ .M1_P )%_T[_P#C_P#]:L:BBP79L_\ "1?]._\ X_\
M_6H_X2+_ *=__'__ *U8U%%@NS9_X2+_ *=__'__ *U'_"1?].__ (__ /6K
M&HHL%V;/_"1?].__ (__ /6H_P"$B_Z=_P#Q_P#^M6-118+LV?\ A(O^G?\
M\?\ _K4?\)%_T[_^/_\ UJQJ*+!=FS_PD7_3O_X__P#6H_X2+_IW_P#'_P#Z
MU8U%%@NS9_X2+_IW_P#'_P#ZU'_"1?\ 3O\ ^/\ _P!:L:BBP79L_P#"1?\
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MF;SBHA,=A.PE)\O 4A,'_6QYQP-QS]UL &-X<\:>(K_7+."]TV9;&:9XM_\
M9ES$ZCRE<.[. BJ&+(><Y P#G(="/$\.MZY<0QE4FU..VMIKF2XF5("(]S"W
MRJ #YL.#USG/(KI8_&^C36L5PETSQS*CI^XD#$/&TB\%<C*HQYZ8YP:JV?CR
MTU*SU*[M CVUFJ$2RLZ!F+,K @(67#*1T- '-R>,/%]U<:@MEIIBBA1Y8VN]
M+GW,528B+[R@DLD?*E@0^!R1B23QEXH;2[>2*R$=[)+(DT<VE7FRW8!MB956
M+J2!F11MX/3<N.DB^(&B3EUCGN&D5UC6,VDP:1F=T&P%?F&Z.3D9&%+?=YJE
MJ_Q+T_1XY3*CR2)<1Q%8XYB(T:2--\I,>(\%^A].O7 !7\8:M/J6FZ9<61OI
MM*F>99SIZW"2.X4B,$PJ95C+@DN@[+U5CG*;Q;XM^SVJ66E"U8V,,@AO;.[N
M'W-$2V7"J"ROM!5V5B Q/)%=%:?%#P[?2I'!=S2.S*AVVDQ"%C&%W'9A<F6/
MKC[WLV)KSXC:!8V*WD]W)':N6$<S6\FV0*"6=3M^90%)W#@\8SD9 ,*^USQI
M:ZA-'%#;SVT27#AETV7=)Y0AVJ&$N,R%Y<<=$P <$U6E\8^+KJYU!;'33%#"
MCRQM=Z7/N8JDQ$7WE!)9(^5+ A\#DC'4ZKXYTW0[N>*^D94C4.#;PS3-C8TC
M%@J$* JDYR<].#@%^M>+8]'N+B+[.TWE:9-J6X-C<L94;>G4[NM &?IOC"Z/
MB2^T[48HX(K5XXUDCB<F9IL&%5Y/*@/O].&^49K)EU[Q#I.O:NSPW]Q8;KDV
M\26$D^2JP;,,.B_-(0/XL-C)&*W?"_BV+5K75KN6SBT]K>4F6W1V>Y  P&FC
MV*5)"\8+ J 0Q%+:_$C0+R1$BNYCNS\YM90BD"0E2^W:"!#)QG^'W&0#E+7Q
MAXHM2+NXLCF]N4L(HYK>:-5D9I$BE",00GRJSC .&!XQ6SXVU:2\TO3-0TIK
MZ]BCN&?[%9Q749O-N5"^;$,H-W(+_NV'7CY@MY\1K:2PNKV'3O,^R:A!9P-?
MA[8%I8XR)/FC+*,2D<*<\^I OP^-S(F#8[I1?-8%89=X+"W,VY3M&0<;1P/7
MVH YRQ\?>(+RWO9!9R3Q@A$FM])N L3^?(F,$DRJ$526C!P>V&&)-)\1>+9X
M[:=M-%J)3%+<0S6EP[$N\"L%+2?(%5I3C&!MSCAL]1X;\1IJ'A^6^GAMK'[/
MN::WMY2YA^4.0X9$*MALD$=P<G-8VH_$B;3(=-FFTR'9?:<]ZL?VLB5&6%I2
MA4QXQM4C=G.?X<9( $\7>*O$.GZW]BT?3GF7RR/,FT^:6+<8W8.'0A2 RJI4
ME3\W'K5&UUSQ1?>+-/LKV.2WMK?49%8V^FW"1W$ 2X59&EW%%&1'\IZG!_B7
M'4>(/&$6AW&DQBW:Z2^D >1&P(8BR)YIXY >6('V8GH#4:?$+1)%E*2W3%)$
MCVBQGW.7D:-=HV?,"Z.,CCC.<8- '/:WJ7BE=4OS8M*QLKB>2&-]/E:*2+[*
M&C3*LHDS)QD$D'(ZXPZ'6O%&M>&?$#2V_P!CO(X";>."VN(IDD#/E074"3Y0
MN"A.23V*UTUCXWT;4[6.XM;IIHY(GF7]Q(&*H$+'!4$8$B<'U]C6?_PL6SFT
MG6-2M86N;73XU<-DJ9#EE9<$?*0RD=Z .:U[5O$6H7;76DQ:LFG-J+!U:VEB
ME^RK:KYGEHZ@AMV_9N !?&,\5U6H:FUQJ'ADV\US;64MQ,CB6.2*21DADVH5
M<!B/E9N1SL!YX-17'CLP^,%T3[''%$)A"U[=3F-&8QQN$CPA#2'S/N%ER 2"
M>0+FJ>--%T_4O[/NWE:\1E9(5M9)68EE4%=JGNZ\]LYZ9- &#H^K7C0:"IDU
M S/K=U"RW\<L$DL.VX925=5W*%V$8&!@ 8QBLN#4M;TVX-W;PZQ=:FHN7U*&
M[@N6MMJL?+$"GY"?N[1%RRY)R:ZK_A/M+N]2T6"SCFO'OW55G^SR*L2O"\JD
ML4P"1']TD'D9[ U]!^(!UJ\M(FLX8X[J[GMHFBN3(Z^4)"2Z[ %)V< $]>O%
M ":#XDUO5&UJ\N;86FG6JR?9(I[&:"27#R;78NP.-JKQM'WLYY &3H7B[Q7K
M-K;RQVL<D;$2-,^F3VXE'V<2&-5D?*YD.T2'((. "036YH_C9M:O["W>QAM;
M6]M4F22XG8-(SHS>7&OE[7("G/S X!..*EC^(6@K&R1R7/[MEC2);&;<^9&B
M&Q=F6&]2,C@<'."#0!P;?%;Q"OB!=.:V:.+%NZW,VC7,2L9, QNK'='E@R(Q
M&&8@9^5C6U?^+/%]F;*VAL?M-[);AII#I4X@61HG<%<.>%8*A5G#<_C6NWCK
MP?J6IAY)H)[VR1Y8I9+1F9%&X,8VV]3L; !RVTX!%3WWQ(TC3]0>VDE91;EO
MM3.CJ80%8J0-OS;BC  <Y% %71]4\377]H1:E"H0QWBP/;V<D+*8IC'&<EVR
M77#C&.G'%9,OBCQ9HGAL))927^HQ!%CDCTV=EEQ;(Y#@,S F0LF[ID8)!&3T
M=K\2_#UY+LCO9,996D:VE6)&42$JTA7:"!#)W_A]QF:3Q_HD,EE'-<2V\EYM
M\E)K:1&(9E5205X!9U SZGT. #*A\0Z_?>$?$4PMY8-4LVE6VD2PE590%#*8
MXY!O?@X^[RP(&[&3DZ;X@\6:=H@,L#W8;RY%GETZY\V-7GF#!D!9V*HL?&T%
M=V2,<#?U?XA1Z79ZG,EB]T]I=M:QQ)( 90B*\LG3Y57<P[Y*@=6 JVWC)(M/
MBO)+?;%_:3:=.1)GR3YK1*_3D%]G'& _MR 8>L>+]?L;G1+:*"&:\N+2.:>"
M#3[B0/(98U8!LCR4"LYS(..,]"#17QEXKFURU1=/F%F&<3Q_V5.F)-LP2+S&
MR&4E$_>K\H)Y.'45>TGXLZ7J*6EU/8W%HTEK-/)B)I98420@ JBDX949\^P'
M)(K5NOB-I5O=!$,TMNKM'-<K!)M#! X"?+^])RH^3/)'?B@#"TSQ1XQO/)D>
MUM_(S$77^S+J-V#20JXQ(4*E0TIZ,,*ISPV3_A(_$%K&\DMK>3W*O/!YRZ?.
M53_2,(3&IPZ[,'>JL2.AQFM73?BMH5U%.;J:33YHKBX@,%Q!*KXA\PEB"@P"
ML;'TSP"34G_"R+!;FP@VL[W$[12RQI+Y,"B.63+2-&!G$1^4XQGZ9 ,W3M8\
M0GPFNH3PW5K?2W]N\T)M))FCA?RO,58_O;1ENG3!]":DL?&&NR1ZN\^FW#"V
MM]ZI'ILR,DWF.OEKN/[\;0K;D]SSN45M6OC[1+S36OK>XEG@6XCM<1VTK/YC
MA2B[ N[D.ISC !YQ@XB/Q)T#RUD%U,8VCCD#_990O[PD(N2N-YP<KU&"2!0!
MR4'BCQ;J5_IHDLYH#%<2OY,>F7,:7,:QW"JSRL0J LL7R, >0<<KAFE>)/&3
M2:U=I$UQ;JGVB-;G1[J$LWE0KL1&;< K&5BJJ2V,#G)/9VOQ$T&_L!>6MXUS
M 4:3]W!)G:"HR05R/OKC/4'(S5*#XJZ RAY[H01R2 0,%=_,C.P(YPORAC(H
M /\ 0X ,BW\8>*=UY%):1NWV5YK>9-*O1&K"0!1)N0-N*L.$5CD,< +SI77B
M[63_ ,(X;?2[M&O1 ]TD]A)\BO(BN&*D^4RJS-AS@8ZGI6I9>/M&U!8?L\MR
M\DS;4A-E,LI_=K)NV% P78Z')&/F Z\5!-\1M(;2]7NK&7[=+IT7F-"JLF\E
MF5 "1T9T9<C/3/0C(!2U#Q#XFL;[4G6R2>RC%P8(X[&4OB/R=O(8[RV^7 "C
M.T =#FI>>*O%5Y'%-IEBL,+3,F+O3)RY0WBQ*Q4NA7$1:0Y'.,\ '.G<>.I+
M+4KRWN;."".">*)-]RRS2JTD2-*J&, HIE'(8]LXS5W5O&4.D>)+/2Y;=VBF
MB+S78/RP$AVC4C'.X12\]BH'\0H X34/%WC32[RYD@L)KV=S'']F;2[DP[5,
MRO,KJ2J\*C^6,LW09++CJ_#FL>)+Y=1GO88&B@@)MH8[.:!IW)<C+2X(^4("
MNP8))SC%6+;XFZ!=3111SW8DD,?#Z?<+MWF,(6RGRY\Z/&<?>]FQ8OO'VAZ?
M;M/-=L(D02.RPN0JEG7<?EZ9C?\ [YH YC3]6\0^(]6T3SH[J&PBU --*MC<
M6?F+]D=BKH[!MHE( )^4G:.2IS8U?6O%5A=ZB=,T]98HYBRQS6\TIGS)$@"L
M9 %&UG/ QQG@!L]!9^+ENCHJFU*-J4LT0P^1'Y8<YZ<YV?K5+0O'9UO5K&T-
MG'9Q75DEVCW$[*\I8$[8EV;9 H'S'<"./EP0: .8M/$'B=;>\U$6UU>R&YWQ
MB33KNW6)/LL6[$!;<X#^80O\1&!\W-3R>-/$EQJ CMK:\6QCE3S+B30[B-RH
MGB4X1@<AD=SQR A.%%=->_$C0=/N+F">XN%FMR?-C2TF<J KL6.U3\N(WY_V
M<=2 7/X[LVUPZ=;PS3[+>XGDG\ITC!B\O*!BNUC^\'0\8[\X .>M_%/B.UO(
M+5-+FY=OW4EE<R!D(E8N9RQ52"J@(3DC@?>7$VB>*/%/_"16-CJEDLMK-M5Y
M;73)XPI,"R%F9F9%4/O3[V[(48.219TSXE&\TO[7+8PKG2Y=55;:Z,HV(%^0
MDHN&.[T(&.]:=CXMDN=4U&UGMH+1+:-I(O-G<2S*H4LX3R\;!N W*S=1QS0!
M@:UXM\5VNNW6G0:&;BT$H@CNX[>7:V_$@?<&X"QK*K$?\M#&!C.*HOJGB[87
MMQ.L]F9)$@FL)WC=/L:LD9;</,)ER,EB0<@\D8ZJ#XC:*T;^;<21R1Q;WVVT
MQC) CW+&Q0;SF6,  9); &00*]U\2;*UR@@FFN/M<=L(4AFR@>5(MTA,>$P7
M[Y!QP<9( *?A_6/$S7UE'/9"'3VF$<J26TS2 ,L[,_F/(< %8@ 1@;L=UQ#K
MWB;Q9INI2"WL8Y=/:XDB#KI\\CPQJ80KG86+[M\G1>P/16SJ2?%3PU&\R"^E
ME:(,S"&TFDPJARS_ "H?E BDY_V>.HS-J7Q(\/Z29/M-Y(B1NZ&06\A3*+ND
M 8+@[1UQWXZ\4 8<?C+Q/+;RVW]E@:G';22&0:;=?9]X$/E[2VW<"7D^7(;Y
M,':0:@U3Q/XGCUN"Q33Y;Q(YV$S1V%S$BJ@0I*)0VQPY)R@)ZX/W6STMQXV@
MM?$EYIDL#B*W@MY!,BN[2R3-(%14"\\1DYSW/  )JYI'B[3->G\JPDFG(MUN
M2_V:14"MG:"Q4#=P?D^\,<@4 <;=7'BS5/[+2Z$D1BNB\K6-M- KJ;!G 8>8
M3@3-M&21D*#DCE;/Q1XJDOK33K>QFCC\N..6YOM.G8H08@S;MP5MP:0YW9!7
M)'!!VT^)%E=ZI!:6437*M*L,CL3&8W+*,%2O/#JWXTMQ\1K6W\2W>C/;.LT4
MT,44C. L^[:92O\ US5E)^OUP <]_P )5X[_ +$2?^S[<WS6'VUD_LN? D\B
M1OLX7S,[MZH.N?FQ@$@BW>>*?%5K=0V0L6GN#<K&;B/39O)>-FC!8$,P0J'<
M_,<?)UZBI;+XH2ZAX:L==M[&QGL;JXCCV1:CNE17QG*^6!YB@[F3=@*K$M@5
MH:U\4-%T>:T"RR7MO-)MDN;2&2:*-3%)("&1&#$B/ 4'/(]@0#GO^$L\26>E
MPW/V.[>>6SC9YI-*NI2TXB8[/(4@IEQ@L !Q@]5(W?"_B?6FV-XDMX[+[0D7
MDQPVDBE)GEE7RB=S;L*B$D =2QPI&+\/C[2@]PEU<"U>-AA'20-M)51N!08(
M+?,!G:,$G%06GQ0\.WTJ1P7<TCLRH=MI,0A8QA=QV87)ECZX^][-@ RM8USQ
M7I]UJ3:7IRSQ12ETBG@FD-QF2) %<OA!M9SP".,XP&RV'Q-K$<]AJ+PWMU;-
M"B7*KI5U%L+2(&(A.7+ $X.#QZX)KHM8\=Z1H>H_8;I[HW65 2"RFE!9E=E4
M,J$9VQN<9X"\XR,U?^%G^'#<K;QWTD\SE1&D%M+(7)*#"A5.>9$SZ9YZ' !R
M&M>)/%6I_P!CA;*[M]PAGFM;?3[M-ZM;R%PTRL-FV3:-A^88&>HQ<UCQUXET
M.S>6[M [3R(MNEKIDKRY,D^45-Y,C".)&.,8#%L8P!T<GQ(T:WC$\D[FTDA6
M>)X;:>1RAC:0LZ"/Y $4GD^W!P#6OO'/AS65:TN8X[RQ(WRK>6LA5U^8H8U,
M9$F2AP..V,G (!6U#Q%XEFTW1KC2/L=VEQ:6TLMPMC++&[22Q(S+AU*JJ.[X
M/. "2 #G.U;Q9XF>S.G'3;H7DD@3[1:V%PH\L>=EPXRJ$F./ )Z/WR#723_$
M?0+&.,/+<I\QB,<=A.QC82+%M8*AVG>RJ!WSD9'-.O/B3H&GP0S7-U)!',C.
MK26\@^[NW _+P1L?.>FTT <S<>*M>TU8I;A)A+]I>UDN)--N&"J;K: L*,!(
M?+P5=0?7D9!B\,^*/&$TEDMYI[6_VRX\R1KJSNB-I:,$+A6\D;"S .1@G!/R
MM7=:QKD%I8:?<"#[5]JN8(H4<;3EW W<C(V@ENF?E[5BZ3\18]4U&"'R((X+
MFZ^SPG[0WG;=LI$C1E  &,1 PS=><$$4 0:IXA\4V-UJ;06,5Q;1K<?9T%E,
M6&SR=C$JQWYWRG"J"VP <@Y@L?&?B'SX;:?36EED<LDT6FW2QF+9,069U7:^
M4B!!QRQP.0:U+KQT]GJ$C2V"IHD=W]@:^,Q\WSL=1%LY3=\N[=G/\..:TK3Q
MCI5_JT>FVTTL]VZ>;M2WDVJNQ7!9]NU<ATQDY.?8X .6_P"$I\5VUQ96TEB+
MNZ>.-W2/3)XXGW1.['S=Q2,JP5=C$DX/=EQ@1>./%FGRZG=RQ;[+*W*S7VE7
MMO&%6&'S$ (;R@/WAW-@$GKPQ/>?\+%T-O,VRW3,KJBH+&?=(6D:,;!LRPWJ
M1D<#@DX()AO/B;X>M6>*6>X9_*:81K9RG?$I(:1?E^90002/4?WAD Y/2/B'
MXHU14,%JC?O"&2XTJ[CD0CRR8W50WEG:Q92Q 8.G/#5I7'BCQC:V,:O9V[73
M2*OGC3;GR^;=' *(9& \QF4MT 7!^;FMJR\8>&M&T^ 6L9TZPDN&@BV6,D,9
MD#[3@;!P6.-P&">^.:M:+X_T;7[U+6SENC,V /.LIH1DQB4+ET R48-CKB@#
MGKCQ1XK@33X_L1DNKJ<[A'IDWE11&81@%MS894RY+[0?TJ"S\3>)X;6PG739
M[N6[CM[:5YK.X0I.Z-^\:,D!(T<'?@#@@YZ5T6E_$+3M0T^YN)$N+>2VR98F
M@DX7S7C5E)4!@3&W(_D03)%\0M%NM%U'5+2::]M;&,22^3 ^X@J& 4$#)((/
MXB@#(L?%'B6;2=;NIK*-)K8#R(%L;DNIWL&^4@>< @4CRR=QSCJM8T?B#Q-I
M>E->K;W=],'NGW2:?=[I(_M3%46#)VL8P-NX#TRH/'5Q_$;2X[C4HKWSK$V3
M29:2"3:Z((RS!MF"?WJ#:,G)QU! GF\?Z+#I<%_Y\TEO,TJ+Y-K+*V8@QDR%
M4D;=C<G@XXSD9 .>O_&'B2'4;Y%T]H[9'\N,+IMS*Z@E-DA95*.N"^[821\H
MQPQK,C\?>,IO+C.C^1+)''(9GTJ\,,;-&3Y384MG>#E@"H&/FRP Z]?B-HDR
M1-;RSW0E:$1F*W?$BR2>6LB$@!DW \C/&#T(S#)\5/#4;S(+Z65H@S,(;2:3
M"J'+/\J'Y0(I.?\ 9XZC(!4M_$7B"^\'^(9_LTD&K69D6WDCL)567"AE,<<@
M#OP<?=Y8$#=C)S-4\9>)O[6@AM+2X6T%RHN&&C7!*0;X@'#'ARP=LJHW*/38
MQKI?^$^T_P#M#48"LJQV(Q*S1/N)^3!4!<%?G'.[.>W>EL_'EE=:7_:*QRR6
MDEY':0/ I<R>9LV/C (!WCZ4 <?J/B#Q/K5[<QQ66HVMM#DQ-':30.2?,!5N
MS8V(05)'S]:O_P#"3>)-)ADN9;2.'3;?>TBW%O,7"A+B0N97D.%!2(<C #8[
MKCL-+\4:=K%U-;VLLCRQIYN&A=0Z;F7<A(&X;E(XSV[$$XMY\3M'\O9:B>^G
M-S%:R0K;R8C\R2-,N=A"C]XIYZ_F0 9FB^.-5U'PA<WYBF>_6\6W$(TN99;<
M%$.98<E\?-NRN?E93ZX?IVL>(=7\)ZS)>PW5OJ>(7A@BM)(3&'BB8JC'[^&+
M@XR1@@^E3Z9\0/#NFZD='LK22QLUC66)X+"6.)]S2[R (PH4")B7SCGW&='3
M?B5X>U:Y-O:WKRS"-I2GV>0$*JJY)^7^ZRG_ ($!UXH Y>\\=>+;>UNY!I3/
M.K-Y4,>EW;[67S/D8[<$,!& Z9!)8D@%:U=+\3:_>WEBMS;S01+JDEM.\>F3
M*DL1B9HV&\;E7=M!<@*&XR1R=Z;QMI%OX?@UN2X<:9,-RS^2Y&W!.XC&<8!.
M:DO/&&EV&K?V;/-,ER "<6TAC&4=P-X7;G;&YQGM[C(!S'B.\E;6/$-H6UIH
MGL[?R&A@O5B24/)N"20)GH8\[3D]">.$GUKQ=!HN@_9+8?:'LK4W?VRRDFD\
MUY8HWW;'0#:K2.1C^'/ !K:OOB3X?T^;RI+JX=\1DB&RGEQO\O9G:AY8S1@#
MK\WL<16OQ+TFXU&2WD,UO" FRYE@D5"S"0E6)7",/*<8)SD>XR <SJ%YXHO6
M9C;7T,R;D9[5)T63;O4,%W$#. >/[PY/%7+?Q3XCM;R"U32YN7;]U)97,@9"
M)6+F<L54@JH"$Y(X'WEQT>B_$#1/$-]'9Z?<37-PP+%5MI0J *K99BN%R'3&
M2"=WL<5-6^)%A:V_^A))>W33V\*1/')&KK+.(1(K;#N4'=T!Z#H&!(!GR^*O
M$.FZ"9M02&*Z-Y:P"6/3)V!22.-I-L(<LQ#,ZC!.,<@X.<S4/&OBZ33[=;?3
M+BWNY+)I)6_LN9@K^3(X9.H!W(B^6WS OMP3767'C72H=0-E>G]\MQY:>5!+
M,JG>B*7;R]J'?(HZ]\YX.*#?%32UUJ2T(>.SC@68W4T4R&3<TJ@1+Y?[SF/
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MJ.3S/L[8,GE R+\^.&XSC-4KO5=8O+>TN?+UZ46.GVXDL_LM[;F\NPLN]-Z
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M2RMN <$EO-QD$'Y<YYQ0!8D\(^$]5O\ 4CY%Q'<228NIH;BY@7<L:Q%-ZLH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
LB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>rxrx-20210813_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rxrx-20210813.xsd" xlink:type="simple"/>
    <context id="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2021-08-13</startDate>
            <endDate>2021-08-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV8xLTEtMS0xLTA_cc6bcb34-3ea7-4d46-9e60-85c9db333e21">0001601830</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV8yLTEtMS0xLTA_2536a590-b32c-471f-9d16-020c9cf21eae">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV8zLTEtMS0xLTA_43245ed0-c211-4427-9bd6-8ec2b2ecc206">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV80L2ZyYWc6YTNiYWM5MDZjNGE0NDM1ZWE1ZjVjNzc4NWU1ZjQwNmMvdGFibGU6YWM2MjQ2ODUwMWY2NDU0Y2JkZWY0NTlkYmE0NzMzMDUvdGFibGVyYW5nZTphYzYyNDY4NTAxZjY0NTRjYmRlZjQ1OWRiYTQ3MzMwNV80LTEtMS0xLTA_4045bef3-6c5a-46d2-a8f8-602ce3ec1a43">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjU0_1fb77831-100f-4a57-9991-337477cb7231">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xMDk5NTExNjI5NDQ3_713c4f8e-6e00-4da2-a6c4-84a432a1a86d">2021-08-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8yMzE_cff701ca-4d43-4637-b552-d26d3fbfac33">Recursion Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6ZDMwYTZiNDRhOGY4NGFiMTgyN2M2MjE0MGUzNzQ4MDcvdGFibGVyYW5nZTpkMzBhNmI0NGE4Zjg0YWIxODI3YzYyMTQwZTM3NDgwN18wLTAtMS0xLTA_5444bcb0-7d7a-4559-a798-35a80816cf89">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6ZDMwYTZiNDRhOGY4NGFiMTgyN2M2MjE0MGUzNzQ4MDcvdGFibGVyYW5nZTpkMzBhNmI0NGE4Zjg0YWIxODI3YzYyMTQwZTM3NDgwN18wLTItMS0xLTAvdGV4dHJlZ2lvbjpjMDNmYjhmZjU1YWE0NTEwODYxNTE5OTA2ZWI2NjllYV81_6b6a52a0-31db-4505-a554-654cca95ca16">001-40323</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6ZDMwYTZiNDRhOGY4NGFiMTgyN2M2MjE0MGUzNzQ4MDcvdGFibGVyYW5nZTpkMzBhNmI0NGE4Zjg0YWIxODI3YzYyMTQwZTM3NDgwN18wLTQtMS0xLTA_9ee11584-04ca-469d-8f00-2b30df1274bb">46-4099738</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8yOTQ_eea946b3-082f-4b91-80f1-ca41ac1e829c">41 S Rio Grande Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8yOTc_c78df273-6bf4-4b28-b75c-4c3bcdeb99a9">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zMDE_aff885b5-2f09-42a2-b1c0-054f853c94ce">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zMDQ_544cc06b-3c90-412f-a2ba-81bb93b5c1bf">84101</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zNjE_b138e4ee-6a10-46e7-8311-a16598aab626">385</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8zNjU_9ff983dc-df54-4dca-9f96-562b21c34279">269 - 0203</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjYw_1678b313-c6ce-4967-81f2-b94e959b62ae">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjYy_6af9d919-2a95-4ac2-8665-016db185944a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjU3_bb208de3-88c2-40c5-aa26-c4112b3549f9">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjU5_01523f30-3e95-4a00-a6fb-04b3322055ef">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6NjE3NGIzNTIyNDUxNDYwYjg2OTgyM2JiZTJlODFjYWUvdGFibGVyYW5nZTo2MTc0YjM1MjI0NTE0NjBiODY5ODIzYmJlMmU4MWNhZV8xLTAtMS0xLTA_bc153ec4-7730-416e-9303-c67127f9e616">Class A Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6NjE3NGIzNTIyNDUxNDYwYjg2OTgyM2JiZTJlODFjYWUvdGFibGVyYW5nZTo2MTc0YjM1MjI0NTE0NjBiODY5ODIzYmJlMmU4MWNhZV8xLTEtMS0xLTA_959758e0-b5e7-45b0-a85b-c7d674447f90">RXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGFibGU6NjE3NGIzNTIyNDUxNDYwYjg2OTgyM2JiZTJlODFjYWUvdGFibGVyYW5nZTo2MTc0YjM1MjI0NTE0NjBiODY5ODIzYmJlMmU4MWNhZV8xLTItMS0xLTA_d4c4ba5f-5657-42ba-a340-cad10d748cdd">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjYz_354e5965-de31-4ac0-ae48-a9abb30d0b81">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813"
      id="id3VybDovL2RvY3MudjEvZG9jOjYyNmU0N2JjMDMzZDQ1MTNiODZiMGMwZDFjNDlmOGU1L3NlYzo2MjZlNDdiYzAzM2Q0NTEzYjg2YjBjMGQxYzQ5ZjhlNV8xL2ZyYWc6YTc4ZjZlM2E0Yzk0NDJiODg4ZjRiM2I5NzIxMjQxNDEvdGV4dHJlZ2lvbjphNzhmNmUzYTRjOTQ0MmI4ODhmNGIzYjk3MjEyNDE0MV8xNjY0_f5b768dd-a73b-4608-a317-0ab6294d25f8">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140178378036024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 13,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Recursion Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4099738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41 S Rio Grande Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269 - 0203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RXRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( /@^#5.JQ"(6,P$  "("   /
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /@^#5,D'INBK0   /@!   :
M          "  ?41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( /@^#5-ED'F2&0$  ,\#   3              "  =H2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "04      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rxrx-20210813.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="rxrx-20210813.htm">rxrx-20210813.htm</File>
    <File>exhibit991-q0221.htm</File>
    <File>rxrx-20210813.xsd</File>
    <File>rxrx-20210813_lab.xml</File>
    <File>rxrx-20210813_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rxrx-20210813.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "rxrx-20210813.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rxrx-20210813_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rxrx-20210813_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rxrx-20210813.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rxrx",
   "nsuri": "http://www.recursion.com/20210813",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rxrx-20210813.htm",
      "contextRef": "ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.recursion.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rxrx-20210813.htm",
      "contextRef": "ie7ec57d670d74503a2ac8812e27fcfb2_D20210813-20210813",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001601830-21-000016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601830-21-000016-xbrl.zip
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M#@IFS:[3[.Q;1'2;:UVEGC:A.X'*L'[QVK7(JN:??_-;VD"RAV[5EVDA<3R
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MHDS0(B+1/0+I;ODGO^#S&.MX$?Y$ +13OH_,#,.,)TB@(8H="<2#88+\Q"4
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MY[6O-2=FMJ,KO9"UI7X$;!MA1T?7EI0-7VN[@4M:Y2FQ3_EE=I_.F98,*C\
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MZ_[CZV#GOU!+ 0(4 Q0    ( /@^#5-CU2;%E"0  (:! 0 4
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H>"TR,#(Q,#@Q,U]P<F4N>&UL4$L%!@     %  4 1@$  /1.      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
